Skip to main content
. 2021 Mar 13;10(3):299. doi: 10.3390/antibiotics10030299

Table 4.

Data pertaining to the clinical course of CDI.

Characteristic CDI–Deceased Group CDI–Control Group p Value
N (%)
or Median (1st, 3rd Quartile)
N Missing N (%)
or Median (1st, 3rd quartile)
N Missing
Body temperature (°C) 36.6 (36.5, 37.1) 127 36.8 (36.6, 37.6) 74 0.005
WBC count (×1000/µL) 13.7 (8.8, 22.3) 14 9.6 (7.2, 14.0) 1 <0.0001
Neutrophil count (×1000/µL) 10.4 (6.1, 18.0) 186 7.2 (4.7, 10.9) 51 <0.0001
CRP (mg/L) 116 (70, 198) 67 65 (23, 120) 17 <0.0001
Serum creatinine (µmol/L) 107 (67, 192) 34 75 (60, 113) 5 <0.0001
Serum albumin (g/L) 24 (20, 28) 173 28 (23, 32) 99 <0.0001
Serum lactate (mmol/L) 1,8 (1.4, 3.3) 356 1.0 (0.8, 1.7) 187 0.0002
Bacteremia 45 (10.8%) 0 6 (2.9%) 0 0.0006
Episode number
1
2
3
4
5

365 (88.0%)
41 (9.9%)
6 (1.4%)
2 (0.5%)
1 (0.2%)
0
177 (84.7%)
22 (10.5%)
5 (2.4%)
5 (2.4%)
0 (0%)
0 0.18
Complications (without deaths) 101 (24.3%) 0 21 (10.0%) 0 <0.0001
Cognitive impairment 92 (22.2%) 0 6 (2.9%) 0 <0.0001
Surgery after CDI diagnosis 10 (2.4%) 0 4 (1.9%) 0 0.78
Days from admission to diagnosis 7 (1, 18) 1 5 (1, 13) 0 0.01
Days from diagnosis to death 12 (4, 25) 0 NA NA NA

CDI, Clostridioides difficile infection; CRP, C-reactive protein; NA, not applicable; WBC, white blood cells.